Annovis Bio (ANVS) Stock Chart & Stock Price History $2.04 +0.06 (+3.08%) Closing price 03:59 PM EasternExtended Trading$2.08 +0.03 (+1.67%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Annovis Bio Stock Price Performance The Annovis Bio (ANVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.00%, with a year-to-date return of -59.42%. In the past month, the stock has increased 28.77%, reflecting recent market activity. As of the latest close, Annovis Bio traded at $1.99 with a market cap of $38.58 million and volume of 277,085 shares. Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.05%1 Month Performance+28.77%3 Month Performance+14.34%Year-To-Date Performance-59.42%1 Year Performance-72.00% ANVS Stock Chart for Tuesday, May, 27, 2025 ANVS Chart by TradingView Annovis Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/27/2025$1.99$2.04+2.56%$2.13$1.97243,892 shs$39.77 million05/26/2025$1.99$1.99$2.06$1.95277,085 shs$38.78 million05/23/2025$2.04$1.99-2.45%$2.06$1.95277,085 shs$28.33 million05/22/2025$2.02$2.04+0.89%$2.10$1.97322,549 shs$29.04 million05/21/2025$2.12$2.02-4.62%$2.13$1.96328,614 shs$28.79 million05/20/2025$2.11$2.12+0.47%$2.20$2.00574,662 shs$30.18 million05/19/2025$1.79$2.11+17.88%$2.12$1.73675,996 shs$30.04 million05/16/2025$1.68$1.79+6.55%$1.80$1.64342,896 shs$25.48 million05/15/2025$1.71$1.68-1.47%$1.73$1.60177,967 shs$23.92 million05/14/2025$1.71$1.71-0.29%$2.08$1.62719,376 shs$24.27 million Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 05/13/2025$1.54$1.71+11.11%$1.73$1.56453,299 shs$24.34 million05/12/2025$1.54$1.54+0.26%$1.64$1.48180,007 shs$21.91 million05/09/2025$1.62$1.54-4.95%$1.74$1.51176,929 shs$21.85 million05/08/2025$1.59$1.62+1.57%$1.68$1.56299,237 shs$22.99 million05/07/2025$1.45$1.59+10.03%$1.65$1.44377,223 shs$22.64 million05/06/2025$1.56$1.45-7.37%$1.55$1.42270,096 shs$20.57 million05/05/2025$1.62$1.56-3.41%$1.68$1.54174,515 shs$22.21 million05/02/2025$1.58$1.62+2.54%$1.75$1.57677,201 shs$22.99 million05/01/2025$1.50$1.58+5.00%$1.65$1.45333,444 shs$22.42 million04/30/2025$1.47$1.50+2.39%$1.52$1.36216,568 shs$21.35 million04/29/2025$1.55$1.47-5.48%$1.61$1.45188,587 shs$20.86 million04/28/2025$1.59$1.55-2.21%$1.60$1.53125,224 shs$22.07 million Related Companies Theratechnologies Stock Chart Black Diamond Therapeutics Stock Chart InflaRx Stock Chart Janone Stock Chart Vigil Neuroscience Stock Chart Vaxart Stock Chart Contineum Therapeutics Stock Chart Neumora Therapeutics Stock Chart Instil Bio Stock Chart C4 Therapeutics Stock Chart Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANVS) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annovis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annovis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANVS Stock Free ANVS Stock Alerts